ReviewTargeted oncology2026

Osimertinib Plus Platinum-Pemetrexed: A Review in Previously Untreated, EGFR-Mutated, Locally Advanced or Metastatic NSCLC.

Amy Zhuang-Yan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.